Shuttle Pharmaceuticals is trading 8.2% down at $3.01 after a string of insider sales and growing dilution concerns tied to its United Dogecoin merger.
- Recent SEC filings show major shareholder HRT Financial LP repeatedly sold shares in early July.
- The merger adds a large block of convertible preferred stock plus a 10-for-1 reverse split, stoking fears about future share overhang and valuation pressure.